| Literature DB >> 35079044 |
Stéphane Bar1, Céline Yee2, Daniel Lichtenstein3, Magali Sellier2, Florent Leviel2, Osama Abou Arab2, Julien Marc4, Matthieu Miclo2, Hervé Dupont2, Emmanuel Lorne2.
Abstract
A fluid challenge can generate an infraclinical interstitial syndrome that may be detected by the appearance of B-lines by lung ultrasound. Our objective was to evaluate the appearance of B-lines as a diagnostic marker of preload unresponsiveness and postoperative complications in the operating theater. We conducted a prospective, bicentric, observational study. Adult patients undergoing abdominal surgery were included. Stroke volume (SV) was determined before and after a fluid challenge with 250 mL crystalloids (Delta-SV) using esophageal Doppler monitoring. Responders were defined by an increase of Delta-SV > 10% after fluid challenge. B-lines were collected at four bilateral predefined zones (right and left anterior and lateral). Delta-B-line was defined as the number of newly appearing B-lines after a fluid challenge. Postoperative pulmonary complications were prospectively recorded according to European guidelines. In total, 197 patients were analyzed. After a first fluid challenge, 67% of patients were responders and 33% were non-responders. Delta-B-line was significantly higher in non-responders than responders [4 (2-7) vs 1 (0-3), p < 0.0001]. Delta-B-line was able to diagnose fluid non-responders with an area under the curve of 0.74 (95% CI 0.67-0.80, p < 0.0001). The best threshold was two B-lines with a sensitivity of 80% and a specificity of 57%. The final Delta-B-line could predict postoperative pulmonary complications with an area under the curve of 0.74 (95% CI 0.67-0.80, p = 0.0004). Delta-B-line of two or more detected in four lung ultrasound zones can be considered to be a marker of preload unresponsiveness after a fluid challenge in abdominal surgery.The objectives and procedures of the study were registered at Clinicaltrials.gov (NCT03502460; Principal investigator: Stéphane BAR, date of registration: April 18, 2018).Entities:
Mesh:
Year: 2022 PMID: 35079044 PMCID: PMC8789825 DOI: 10.1038/s41598-022-05251-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(A) Pleural line (vertical arrows indicate the bat sign, with ribs and pleural line). One A-line at the standardized location (horizontal arrows). (B) B-lines. 6 B-lines visible between two ribs in short-axis. (C) BLUE-points. The BLUE-protocol uses three points per lung. Two hands are applied this way, against the clavicule. Two points are anterior, the upper-BLUE-point (middle of upper hand, that is, roughly, second intercostal space between parasternal and anterior axillary line) and the lower-BLUE-point (middle of lower palm). One point, continuing transversally the lower BLUE-point as «posterior as possible, is the posterolateral alveolar pleural syndrome-point» (PLAPS-point). Note that the PLAPS-point seems rather cranial, but is in actual fact just a bit above the diaphragm usually. (D) The lateral point. For adapting the approach to the perioperative setting with its constraints in this study, we took a clinically accessible lateral point located transversally between lower BLUE-point and PLAPS-point, and longitudinally between anterior and posterior axillary line. Note that, if a theoretical point is not accessible for any reason, device or other, the BLUE-points are flexible up to a large tolerance (indicated by the areas in the cartouche).
Figure 2Study protocol.
Figure 3Flow chart of the study.
Comparison of baseline characteristics, hemodynamic, echography, and ventilation parameters, at baseline and after the first fluid challenge of 250 ml, between responding and non-responding patients.
| Characteristics | Responders (n = 133) | Non-responders (n = 64) | p-values |
|---|---|---|---|
| 61 [47–70] | 62 [48–71] | 0.88 | |
| 59 (44%) | 26 (40%) | 0.28 | |
| 2 [2–3] | 2 [2–3] | 0.25 | |
| 25 [22–29] | 27 [22–31] | 0.29 | |
| Arterial hypertension | 58 (44%) | 23 (36%) | 0.26 |
| Myocardial infarction | 7 (5%) | 5 (8%) | 0.41 |
| Cardiac dysfunction | 2 (2%) | 0 | 0.26 |
| OSAS | 10 (8%) | 4 (6%) | 0.25 |
| Smoking | 23 (17%) | 8 (13%) | 0.47 |
| Arteritis | 4 (3%) | 0 | 0.16 |
| Stroke | 8 (6%) | 3 (5%) | 0.78 |
| Diabetes | 23 (17%) | 12 (19%) | 0.73 |
| Dyslipidemia | 28 (21%) | 11 (17%) | 0.50 |
| Chronic renal disease | 7 (5%) | 4 (6%) | 0.77 |
| Baseline | 69 [61–81] | 73 [63–81] | 0.61 |
| 250 ml | 66 [58–80] * | 71 [68–80] | |
| Baseline | 70 [64–78] | 75 [65–82] | 0.10 |
| 250 ml | 69 [63–79] | 75 [68–83] | |
| Baseline | 2.5 [2.0–3.2] | 2.8 [2.3–3.3] | 0.08 |
| 250 ml | 2.9 [2.3–3.5]* | 2.7 [2.2–3.5] | 0.54 |
| Baseline | 99 ± 1 | 98 ± 2 | |
| 250 ml | 99 ± 1 | 98 ± 2 | |
| Baseline | 0 [0–1] | 0 [0–4] | |
| 250 ml | 1 [0–3]* | 4 [2–7]* | |
| 6.3 [5.6–7.1] | 6.4 [6.0–7.1] | 0.30 | |
| 5 [5–6] | 5 [5–6] | 0.76 | |
| 17 [15–19] | 17 [15–19] | 0.98 | |
Significant values are in bold.
Values are means ± SD, numbers (proportion) or median [IQR].
ASA-PS American Society of Anesthesiology-Physical status, BMI body mass index, HR heart rate, MAP mean arterial pressure, OSAS obstructive sleep apnea syndrome, SpO pulsed oxygen saturation, PEEP positive end-expiratory pressure. The p-value refers to the intergroup comparison. *p < 0.05 for the intragroup effect.
Figure 4Analysis of the Delta-SV value according to the Delta-B-line. n = the number of datapoints for each value of the Delta-B-line. *p < 0.05 for the comparison to the Delta-SV for 0 Delta-B-line. Figure generated from MedCalc Statistical Software version 19.7 (MedCalc Software Ltd, Ostend, Belgium; https://www.medcalc.org; 2021).
Comparison of baseline characteristics, echography, intraoperative, and postoperative parameters as a function of the occurrence of postoperative pulmonary complications.
| Characteristics | Non-pulmonary complications (n = 181) | Pulmonary complication (n = 16) | p-value |
|---|---|---|---|
| 61 [47–70] | 66 [61–72] | ||
| 2 [2–3] | 2 [2–3] | 0.26 | |
| Arterial hypertension | 70 (39%) | 11 (69%) | |
| Myocardial infarction | 11 (6%) | 1 (6%) | 1.00 |
| Cardiac dysfunction | 1 (0.6%) | 1(6%) | 0.05 |
| OSAS | 12 (7%) | 2 (13%) | 0.38 |
| Smoking | 31 (17%) | 0 (0%) | 0.07 |
| Arteritis | 2 (1%) | 2 (13%) | |
| Stroke | 9 (5%) | 2 (13%) | 0.19 |
| Diabetes | 31 (17%) | 4 (25%) | 0.42 |
| Dyslipidemia | 35 (19%) | 4 (25%) | 0.26 |
| Chronic renal disease | 10 (6%) | 1 (6%) | 1.00 |
| Digestive | 157 (87%) | 15 (94%) | 0.42 |
| Urological | 14 (8%) | 1 (6%) | 0.78 |
| Gynecological | 10 (5%) | 0 (0%) | 0.36 |
| 3.1 [2.5–3.7] | 3.4 [2.4–3.8] | 0.69 | |
| 4 [2–7] | 7 [5–12] | ||
| 60 (33%) | 9 (56%) | 0.07 | |
| 0.00 [0.00–0.04] | 0.05 [0.00–0.08] | 0.11 | |
| 9.4 [5.7–16.7] | 8.4 [6.7–13.2] | 0.67 | |
| 4.9 [2.5–7.4] | 6.4 [4.5–8.7] | 0.66 | |
| 120 [60–210] | 200 [130–240] | ||
| 343 [273–419] | 290 [173–402] | 0.09 | |
| 34 [16–92] | 37 [13–120] | 1.00 | |
| 4 [2–8] | 18 [13–36] | ||
Significant values are in bold.
Values are means ± SD, numbers (proportion) or median [IQR].
Digestive surgery duodenopancreatectomy, hepatectomy, colectomy, gastrectomy, oesophagectomy, intraperitoneal hyperthermic chemotherapy. Urological surgery: cystectomy, nephrectomy, Gynecological surgery hysterectomy and ovariectomy, OSAS obstructive sleep apnea syndrome, ASA-PS American Society of Anesthesiology-Physical status, PaO/FiO arterial oxygen partial pressure to fractional inspired oxygen ratio.
Univariable and multivariable logistic regression analysis for postoperative pulmonary complications.
| Variables | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| OR (CI 95%) | p-value | OR (CI 95%) | p-value | |
| Age | 1.04 (1.01–1.09) | 1.05 (0.99–1.10) | 0.081 | |
| Arterial hypertension | 3.49 (1.21–11.46) | 2.99 (0.97–9.48) | 0.076 | |
| Arteritis | 12.79 (1.45–113.40) | 10.47 (0.99–106.23) | 0.059 | |
| Delta-B-line | 1.21 (1.06–1.37) | 1.22 (1.06–1.41) | ||
| Intraoperative duration | 1.00 (1.00–1.01) | 1.01 (0.99–1.01) | 0.069 | |
Significant values are in bold.
Values are odds ratio (OR) with 95% CI.